Kellie Turner

Kellie Turner is a Senior Director in Global PK/PD/Pmx at Eli Lilly and Company, where they have been instrumental as a Chorus PK/PD and Asset Manager since 2022. Previously, they served as a Senior Research Scientist and Principal Research Scientist at the same company, focusing on PK/PD science. Kellie gained foundational experience as a Research Associate at Newcastle University and completed a Ph.D. in Pharmaceutical Sciences at the University of Tennessee Health Science Center. They also hold a Pharm.D. and a B.S. in Biochemistry from the University of Tennessee Health Science Center and Boston College, respectively.